What kind of Thai Patients factors to Request Prescribing from Physicians
DOI:
https://doi.org/10.14738/abr.31.871Abstract
ABSTRACT
This study investigates the Thai healthcare system in regard to the factors influencing the practice of prescribing in the pharmaceutical industry. The healthcare system in Thailand is shifting towards one in which informed patients make their own medical decisions. The sudden increase of channels directed to both patients and medical practitioners makes it very difficult for pharmaceutical companies to control the value of information related to the practice of prescribing.
Accordingly, the purpose of this study was to examine the influence of patients influencing factors several marketing channels and their influence on the practice of prescribing.
The findings of the study indicated that the study is useful in understanding the variables that influence prescription patterns of patients in the Thai healthcare system. The patients, there was no significant correlation between the patients’ experience with the medication and their intent to request the same medication.
Understanding the marketing channels and their relationship with prescribing practices has implications for the development of marketing strategies in the pharmaceutical industry.
Keywords: Thai healthcare, prescribing, pharmaceutical industry, patients
References
REFERENCES:
Agrawal, M. (1999). Global competitiveness in the pharmaceutical industry: The effect of national regulatory, economic and market factors. New York: Pharmaceutical Products Press Haworth Press.
Alperstein, N. M., & Peyrot, M. (1993). Consumer awareness of rescription drug advertising. Journal of Advertising Research, 4, 50-56.
American Medical Association Online. (2004). Ethics Journal of the American Medical Association. Retrived January 21, 2004, from http://www .ama-assn.org
Bates, A. (2003). Marketing to win market share: The role of doctor sentiment and benchmarking. International Journal of Medical Marketing, 3(2), 144-145.
Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Ten years of direct-to-consumer prescription drug advertising. American Journal of Law and Medicine, 25(1), 149-167.
Business Monitor International (2006). Thailand Pharmaceutical and Healthcare Report Q4, 5-54.
Calla L. Hogue (May, 2009). The impact of direct-to-consumer pharmaceutical advertising on the physician/patient conversation. South Dakota State University. Thesis Abstracts International. (UMI No. 1471061)
Carolyn, S. (2004). Factors influencing prescribing in the pharmaceutical industry: Patients and physicians intent. Nova Southeastern University, USA. Dissertation Abstracts International, 59(10), 3890-A. (UMI No. 3144712)
Coleman, J. S., Katz, E., & Menzel, H. (1996). Medical innovation, diffusion study.
New York: n.p.
Denig, P., Haaijer-Ruskamp, F. M., Wesseling, H., & Versluis, A. (1991). Impact of clinical trials on the adoption of new drugs within a university hospital. European Journal of Clinical Pharmacology, 41(2), 325-328.
Findlay, S. (2002). Do ads really drive pharmaceutical sales?. Marketing Health Services, 38, 79-92.
Gonul, F. F., Carter, F., Petrova, E., & Srinivasan, K. (2001, July). Promotion of
prescription drugs and its impact on physicians’ choice behavior. Journal of Marketing, 65(3), 79-92.
IMS Health. (2006). IMS health report global pharmaceutical market. Bangkok,
Thailand: Author.
IMS Health Quarterly Market Brief. (2006). Top 10 Pharmaceutical Companies in Thailand. Bangkok, Thailand: Author.
Johnson, G. L., Arkalgud R. (2000). Patient-physician relationships in the information age. Marketing Health Services, Chicago, 20(1), 20-28.
Katen, K. (2004, April). Staying flexible. Executive Excellence, 21(4), 14-29.
Lipsky, M. S., & Taylor, C. A. (1997). The opinions and experience of family physicians regarding direct-to-consumer advertising. Journal of Family Practice, 3180, 495-499.
Magazine Publishers of America. (1999). Magazines: A healthy diagnosis. return on investment for DTC pharmaceutical advertising. A Study Measuring the Effectiveness of Allergy Advertising, 21300, 1-12.
Osgood, C. E., Suci, G. J., & Tannenbaum, P. H. (1957). The measurement of meaning. Urbana: University of Illinois Press.
Park, J. S., and Grow, A. (2007). The Social Reality of Depression: DTC Advertising of Antidepressants and Perceptions of the Prevalence and Lifetime Risk of Depression. Journal of Business Ethics, DOI 10.1007/s10551-007-9403-7.
Pharmaceutical Engineering, Country Profile. (2006, July). A look at the pharmaceutical industry in Thailand. The Office Journal of ISPE, 26(1), 1-8.
The Pharmaceutical Industry in Thailand. (2006, June). Royal Danish Embassy. Bangkok: Author.
Pharmaceutical Review. (2003). Attention deficit hyperactivity disorder (ADHD), Retrieved February 14, 2003, from http://www .pharmaceuticalreview.com
Protocare Sciences. (2001). No significant difference in the risk of diabetes mellitus during treatmentwith typical versus atypical. Antipsychotics, CA: Author.
Rogers, E., & McKenna, S. D. (1993). Managing takeover: Learning disabilities and the cultural dimension. Journal of Managerial Psychology, 8(2), 3-10.
Royal Danish Embassy, Bangkok Danish Trade Council. (2006). Sector Overview The Pharmaceutical Industry in Thailand. Bangkok: Author.
Schnuer, J. (2001). DCT marketers eye ethic media. Advertising Age, 72(12), 39.
Segal, R., & Wang, F. (1999). Influencing physicians prescribing. Pharmacy Practice Management Quarterly, 19(3), 30-50.
Thailand Pharmaceutical and Healthcare Report Q4. (2006, December). Part of BMI's Industry Survey & Forecasts, Published. Bangkok: Business Monitor International.
Williams, A. (2001). Consolidation Revisited. Journal of Commercial Biotechnology, 8(2), 130-139.
